COVID-19 convalescent plasma no real help to at-risk ED patients, study confirms

Aug 19, 2021 - 02:34 PM
COVID19 Web Sized

In a federally funded study that enrolled more than 500 patients from U.S. hospital emergency departments, administering COVID-19 convalescent plasma to high-risk COVID-19 outpatients with early symptoms did not prevent disease progression, according to final results reported yesterday in the New England Journal of Medicine. Funded by the National Institutes of Health and Biomedical Advanced Research and Development Authority, the clinical trial was halted in February after an independent board concluded that the treatment was unlikely to help such patients. 

“We were hoping that the use of COVID-19 convalescent plasma would achieve at least a 10% reduction in disease progression in this group, but instead the reduction we observed was less than 2%,” said Clifton Callaway, M.D., principal investigator and professor of emergency medicine at the University of Pittsburgh.
 

Related News Articles

Headline
CDC issues advisory on increased parvovirus B19 cases in the U.S. 
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Blog
RAND 5.0 – The Health Policy Equivalent of Groundhog Day
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
CDC encourages older adults to get additional COVID-19 vaccine dose 
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
NASEM releases evidence review on COVID-19 vaccine safety
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
FDA approves combo test for flu, COVID-19; alerts providers to medical device risks 
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
CDC recommends additional dose of updated COVID-19 vaccine for older adults
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…